Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 4, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Testis specific lactate dehydrogenase as target for immunoliposomes.

Ranjna C Dutta1, Erwin Goldberg

  • 1Department of Biochemistry, Molecular Biology and Cell Biology Northwestern University, Evanston, IL 60208, USA. ranjna_dutta@rediffmail.com

American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|July 3, 2008
PubMed
Summary

Targeting the testis for drug delivery is possible using immunoliposomes. These specifically target lactate dehydrogenase-C4 (LDH-C(4)) on sperm and testes, enabling agent delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

L-2-hydroxyglutarate regulates centromere and heterochromatin conformation in the male germline.

PLoS genetics·2025
Same author

Editorial: Endocrine and paracrine regulation of spermatogenesis.

Frontiers in endocrinology·2022
Same author

Exposed and Sequestered Antigens in Testes and Their Protection by Regulatory T Cell-Dependent Systemic Tolerance.

Frontiers in immunology·2022
Same author

The sperm-specific form of lactate dehydrogenase is required for fertility and is an attractive target for male contraception (a review).

Biology of reproduction·2020
Same author

Preclinical contraceptive development for men and women.

Biology of reproduction·2020
Same author

Celebrating the Silver Anniversary of the North American Testis Workshop.

Andrology·2020

Area of Science:

  • Reproductive biology
  • Nanomedicine
  • Drug delivery systems

Background:

  • The testis presents a unique challenge for targeted therapeutic agent delivery.
  • Developing specific delivery mechanisms is crucial for reproductive health interventions.

Purpose of the Study:

  • To investigate the feasibility of targeted therapeutic agent delivery to the testis.
  • To evaluate immunoliposomes engineered for testis-specific targeting.

Main Methods:

  • Immunoliposomes were created by incorporating antibodies against lactate dehydrogenase-C4 (LDH-C(4)).
  • LDH-C(4) is a protein specifically expressed in the testis.
  • Targeting and delivery capabilities were assessed in vitro and in vivo.

Main Results:

More Related Videos

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins
08:46

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins

Published on: September 22, 2020

Related Experiment Videos

Last Updated: Jul 4, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins
08:46

Cell-Free Production of Proteoliposomes for Functional Analysis and Antibody Development Targeting Membrane Proteins

Published on: September 22, 2020

  • LDH-C(4)-immunoliposomes demonstrated specific recognition of antigens on spermatozoa and testicular tissues.
  • Effective targeting was observed in both in vitro and in vivo experimental models.

Conclusions:

  • Targeting lactate dehydrogenase-C4 (LDH-C(4)) is a viable strategy for delivering agents to the testis.
  • This approach holds potential for both therapeutic and anti-spermatogenic applications.